Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study∗Elena Butz, Peggy Sekula, Ulla T. Schultheiss et al.|Kidney Medicine|2026Cited by 0